PARK7 (NM_007262) Human Recombinant Protein
Specifications
| Product Data | |
| Species | Human |
|---|---|
| Expression Host | HEK293 |
| Expression cDNA Clone or AA Sequence | |
| Tag | C-Myc/DDK |
| Predicted MW | 19.7 kDa |
| Concentration | >0.05 µg/µL as determined by microplate BCA method |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Buffer | 25 mM Tris-HCl, 100 mM glycine, pH 7.3, 10% glycerol |
| Preparation | Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. |
| Note | For testing in cell culture applications, please filter before use. Note that you may experience some loss of protein during the filtration process. |
| Storage | Store at -80°C. |
| Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
| Shipping | Dry Ice |
| Reference Data | |
| RefSeq | NP_009193 |
| Locus ID | 11315 |
| UniProt ID | Q99497 |
| Cytogenetics | 1p36.23 |
| RefSeq Size | 979 |
| RefSeq ORF | 567 |
| Synonyms | DJ-1; DJ1; GATD2; HEL-S-67p |
| Summary | The product of this gene belongs to the peptidase C56 family of proteins. It acts as a positive regulator of androgen receptor-dependent transcription. It may also function as a redox-sensitive chaperone, as a sensor for oxidative stress, and it apparently protects neurons against oxidative stress and cell death. Defects in this gene are the cause of autosomal recessive early-onset Parkinson disease 7. Two transcript variants encoding the same protein have been identified for this gene. provided by RefSeq, Jul 2008 |
| Protein Categories | Cytokines, Enzyme: Peptidases, Intracellular Proteins, Nervous system: Neurodegenerative diseases |
| Protein Families | Druggable Genome, Protease |
| Protein Pathways | Parkinson's disease |
Reviews
Documents
| FAQs |
| SDS |
Resources
| Recombinant Protein Resources |
Other "PARK7" proteins (6)
| SKU | Description | Size | Price | |
|---|---|---|---|---|
| PH325206 | PARK7 MS Standard C13 and N15-labeled recombinant protein (NP_001116849) | 10 ug |
$3,360.00
|
|
| LC402122 | Lyophilized PARK7 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC426614 | Lyophilized PARK7 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LY402122 | Transient overexpression lysate of Parkinson disease (autosomal recessive, early onset) 7 (PARK7), transcript variant 1 (as WB positive control) | 100 ug |
$436.00
|
|
| LY426614 | Transient overexpression lysate of Parkinson disease (autosomal recessive, early onset) 7 (PARK7), transcript variant 2 (as WB positive control) | 100 ug |
$436.00
|
|
| TP325206 | Recombinant protein of human Parkinson disease (autosomal recessive, early onset) 7 (PARK7), transcript variant 2, 20 µg | 20 ug |
$737.00
|
|
Citations
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.